Acquisition Expands Henry Schein
One's International Presence and Enhances Its
Software Solutions Portfolio
MELVILLE, N.Y., Feb. 13, 2019 -- Henry
Schein One announced today that it has acquired Kopfwerk, the leading dental
practice management solutions company in Vienna, Austria. Kopfwerk is a
full-service software company that delivers state-of-the-art practice
management solutions, along with technical support, training, and installation,
to boost office productivity, automate clinical and office processes, and enhance
patient care.
Founded
in 1987 by Peter Schiller and Thomas Gessl, Kopfwerk had 2018 revenues of
approximately $2.2 million. Henry Schein expects this transaction to be neutral
to its 2019 earnings per share and to be accretive thereafter. Additional
financial details and terms were not disclosed.
Henry
Schein One is a joint venture between Henry Schein, Inc. and Internet Brands
that delivers integrated technology to enhance dental practice management.
The
company includes Henry Schein's market-leading solutions of Dentrix, Dentrix
Ascend, Dentrix Enterprise, Easy Dental, and TechCentral, as well as
international companies, including Software of Excellence, Logiciel Julie,
InfoMed, Exan, and LabNet, among others. Also included in Henry Schein One are
the dental businesses of Internet Brands, including web-based solutions such as
Demandforce, Sesame Communications, Officite, DentalPlans.com and more.
"We
are delighted about our new partnership with Kopfwerk. It's the newest addition
to Henry Schein One's software portfolio and we believe it will further enhance
our ability to power successful practices by providing our customers in Austria
with the latest in value-added services and technology solutions," said
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry
Schein. "Kopfwerk will bolster our suite of comprehensive solutions that health
care professionals rely on to operate a more efficient practice and provide
patients with quality care."
"Kopfwerk
will become an integrated part of Henry Schein One's portfolio of technology
solutions, which include the Dentrix family of practice management systems,
Easy Dental, Demandforce, Sesame Communications, Officite, and other global
companies dedicated to delivering end-to-end management and marketing systems
to improve management, profitability, and the entire patient experience," said
James A. Harding Jr., Chief Executive Officer, Henry Schein One.
"Kopfwerk's highly regarded solution will complement these offerings as
well as our mission to enable a true digital workflow that helps dental teams
become more productive and improve each stage of the patient experience."
Kopfwerk's Peter Schiller will continue to
serve as General Manager of the Company.
"Henry Schein's excellent reputation and
extensive reach among dentists bodes well for our continued success and we are
excited to become a part of this team," Mr. Schiller said. "We share with Henry Schein One a commitment
to help accelerate the adoption of digital technology and solutions to help
dental practices grow and prosper for the ultimate benefit of the patient."
Henry
Schein One, founded in 2018, is the world's largest dental practice management
software company. Headquartered in American Fork, Utah, the company integrated
13 companies, 40 plus software brands, and employs approximately 1,500 people. For
more information, visit www.henryscheinone.com
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq:
HSIC) is a solutions company for health care professionals powered by a network
of people and technology.
With more than 18,000 Team Schein Members worldwide, the Company's network of trusted advisors
provides over 1 million customers globally with more than 300 valued solutions
that improve operational success and clinical outcomes. Our Business, Clinical,
Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can
provide quality care more effectively. These solutions also support dental laboratories, government and institutional health
care clinics, as well as other alternate care
sites.
Henry Schein operates through a
centralized and automated distribution network, with a selection of more than
120,000 branded products and Henry Schein private-brand products in stock, as
well as more than 180,000 additional products available as special-order items.
A Fortune 500® Company and a member
of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is
headquartered in Melville, N.Y., and has operations or affiliates in 31
countries. The Company's sales, including the animal health business,
reached a record $12.5 billion in 2017, and have grown at a compound
annual rate of approximately 15% since Henry Schein became a public company in
1995.
For more information, visit Henry
Schein at www.henryschein.com, Facebook.com/HenrySchein
and @HenrySchein on Twitter.
Cautionary
Note Regarding Forward-Looking Statements
In accordance with the "Safe Harbor"
provisions of the Private Securities Litigation Reform Act of 1995, we provide
the following cautionary remarks regarding important factors that, among
others, could cause future results to differ materially from the forward-looking
statements, expectations and assumptions expressed or implied herein. All
forward-looking statements made by us are subject to risks and uncertainties
and are not guarantees of future performance. These forward-looking
statements involve known and unknown risks, uncertainties and other factors
that may cause our actual results, performance and achievements or industry
results to be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements.
These statements are identified by the use of such terms as "may,"
"could," "expect," "intend," "believe,"
"plan," "estimate," "forecast,"
"project," "anticipate" or other comparable terms. A
full discussion of our operations and financial condition, including factors
that may affect our business and future prospects, is contained in documents we
have filed with the United States Securities and Exchange Commission,
or SEC, and will be contained in all subsequent periodic filings we make
with the SEC. These documents identify in detail important risk factors
that could cause our actual performance to differ materially from current
expectations.
Risk factors and uncertainties that could cause
actual results to differ materially from current and historical results
include, but are not limited to: effects of a highly competitive and
consolidating market; our dependence on third parties for the manufacture and
supply of our products; our dependence upon sales personnel, customers,
suppliers and manufacturers; our dependence on our senior management;
fluctuations in quarterly earnings; risks from expansion of customer purchasing
power and multi-tiered costing structures; increases in shipping costs for our
products or other service issues with our third-party shippers; general global
macro-economic conditions; risks associated with currency fluctuations; risks
associated with political and economic uncertainty; disruptions in financial
markets; volatility of the market price of our common stock; changes in the
health care industry; implementation of health care laws; failure to comply
with regulatory requirements and data privacy laws; risks associated with our
global operations; transitional challenges associated with acquisitions and
joint ventures, including the failure to achieve anticipated synergies;
financial risks associated with acquisitions and joint ventures; litigation
risks; the dependence on our continued product development, technical support
and successful marketing in the technology segment; increased competition by
third party online commerce sites; risks from disruption to our information
systems; cyberattacks or other privacy or data security breaches; certain
provisions in our governing documents that may discourage third-party
acquisitions of us; and changes in tax legislation. The order in which these
factors appear should not be construed to indicate their relative importance or
priority.
We caution that these factors may not be exhaustive
and that many of these factors are beyond our ability to control or
predict. Accordingly, any forward-looking statements contained herein
should not be relied upon as a prediction of actual results. We undertake
no duty and have no obligation to update forward-looking statements.
CONTACTS:
Media
Ann
Marie Gothard
Vice
President, Corporate Media Relations
annmarie.gothard@henryschein.com
(631)
390-8169